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ApoptosisNε-acetylation occurs on select lysine residues in α-crystallin of the human lens and alters its chaperone func-
tion. In this study, we investigated the effect of Nε-acetylation on advanced glycation end product (AGE) forma-
tion and consequences of the combined Nε-acetylation and AGE formation on the function of α-crystallin.
Immunoprecipitation experiments revealed that Nε-acetylation of lysine residues and AGE formation
co-occurs in both αA- and αB-crystallin of the human lens. Prior acetylation of αA- and αB-crystallin with
acetic anhydride (Ac2O) before glycation with methylglyoxal (MGO) resulted in signiﬁcant inhibition of the
synthesis of two AGEs, hydroimidazolone (HI) and argpyrimidine. Similarly, synthesis of ascorbate-derived
AGEs, pentosidine and Nε-carboxymethyl lysine (CML), was inhibited in both proteins by prior acetylation. In
all cases, inhibition of AGE synthesis was positively related to the degree of acetylation. While prior acetylation
further increased the chaperone activity of MGO-glycated αA-crystallin, it inhibited the loss of chaperone
activity by ascorbate-glycation in both proteins. BioPORTER-mediated transfer of αA- and αB-crystallin into
CHO cells resulted in signiﬁcant protection against hyperthermia-induced apoptosis. This effect was enhanced
in acetylated and MGO-modiﬁed αA- and αB-crystallin. Caspase-3 activity was reduced in α-crystallin trans-
ferred cells. Glycation of acetylated proteins with either MGO or ascorbate produced no signiﬁcant change in
the anti-apoptotic function. Collectively, these data demonstrate that lysine acetylation and AGE formation
can occur concurrently in α-crystallin of human lens, and that lysine acetylation improves anti-apoptotic
function of α-crystallin and prevents ascorbate-mediated loss of chaperone function.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Crystallins account for more than 90% of vertebrate lens proteins,
and α-crystallin accounts for 40–50% of lens crystallins. α-Crystallin
is composed of two sub units, αA- and αB-crystallin [1]. They exist
as large oligomers of 30–40 subunits in a preferred ratio of 3:1
(αA:αB) in the human lens [2]. α-Crystallin is essential for both struc-
tural integrity of the lens and for keeping other lens proteins soluble
[3]. While αA-crystallin is predominantly present in the lens with
small amounts in the retina, αB-crystallin is present, in addition to
the lens, in a wide variety of tissues, such as skeletal muscle, heart,
kidney, brain, and retina [4–6]. Both αA- and αB-crystallin are chaper-
one proteins. They bind to structurally perturbed proteins and preventology and Visual Sciences,
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rights reserved.their denaturation [7]. In the lens,α-crystallin binds to other crystallins
(β- and γ-crystallins) and cytoskeletal proteins, and prevents their
denaturation from age-associated stresses, such as oxidation [8].
α-Crystallin is a robust anti-apoptotic protein, and it inhibits apoptosis
of cells through different mechanisms: by binding to procaspase-3 and
Bax, inhibiting cytochrome-C release from the mitochondria, by acti-
vating PI3 kinase, by promoting the activation of PDK-1 and AKT, and
by inhibiting PTEN [9–12].
The lens grows throughout lifewith very little protein turnover; this
entails accumulation of post-translationalmodiﬁcations of lens proteins
throughout life [13]. The major modiﬁcations include glycation,
acetylation, deamidation, truncation, phosphorylation, oxidation, and
carbamylation [14–18]. Previous reports indicate that the N-terminal
residue in α-crystallin can be readily acetylated, and acetylation leads
to alterations in protein structure [19–22]. Nε-acetylation of epsilon
group of lysine is another modiﬁcation. Aspirin has been used as an
anti-cataract agent [23]; it inhibits cataract development in experimen-
tal animals possibly through Nε-acetylation of lysine residues in lens
proteins. In fact, one previous study has shownNε-acetylation of specif-
ic lysine residues in aspirin-treated lens proteins [24]. We previously
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and K99, and in αB-crystallin were K92 and K166 [25]. We showed
that in vitro acetylation of αA-crystallin alters its chaperone function.
Glycation is another signiﬁcant post-translational modiﬁcation in
proteins [26]. Both intracellular and extracellular proteins are targets
for this modiﬁcation. The glycation reaction occurs between carbonyl
compounds and free amino groups in proteins. The Amadori product,
the ﬁrst stable product of the reaction, is transformed by a series of re-
actions into a variety of stable products that are collectively known as
advanced glycation end products or AGEs. Some AGEs are ﬂuorescent
and some are formed as amino acid crosslinking adducts in proteins
[17]. Formation of AGEs due to glycation alters the surface charge on
the protein leading to conformational changes, which in turn affect
protein–protein and protein–water interactions [27]. These properties
of AGEs have detrimental effects on the transparency of the lens.
Methylglyoxal (MGO) has been identiﬁed as one of themajor precur-
sors of AGEs in the human lens. MGO is primarily derived from triose
phosphate intermediates of glycolysis [28–31]. Glycation byMGO occurs
mainly on arginine residues. Hydroimidazolone and argpyrimidine are
two of such AGEs, and both are present in human lenses. Ascorbic acid
is a major antioxidant in lens, but its oxidation products are strong pre-
cursors of AGEs [32–34]. K2P, vesperlysine, pentosidine, carboxymethyl
lysine (CML), and OP-lysine are some of the AGEs in the human lens
produced from ascorbate oxidation products [35]. These AGEs accumu-
late with age in the lens, and their accumulation occurs at a higher rate
in cataractous lenses [35].
The fact that α-crystallin is the most abundant protein in the
lens, coupled with the fact that it does not turnover during the
lifespan of an individual, suggest that post-translational modiﬁca-
tions of this protein not only affect transparency of the lens, but
could also affect its two important functions, chaperoning and
anti-apoptosis. With this in mind, we investigated the effects of
acetylation and glycation on the chaperone and anti-apoptotic func-
tion of αA- and αB-crystallin.
2. Materials and methods
Acetic anhydride, MGO, ascorbic acid and lysozyme were obtained
from Sigma-Aldrich Chemical Co. LLC (St. Louis, MO, USA). All
chemicals were of analytical grade. Non-cataractous human lenses
were obtained from Heartland Lions Eye Bank, St. Louis, MO. Senile
cataractous lenses (age: 65–78 years) were obtained from Illadevi
Cataract and IOL Research Centre, Ahmedabad, India.
2.1. Nε-acetyllysine in human lens αB-crystallin
Previously we reported the occurrence of Nε-acetyllysine in human
lens αA-crystallin [25]. Here we determined Nε-acetyllysine in
αB-crystallin of aging and cataractous lenses. Lenses were stored at
−80 °C until use. The water-soluble fraction was prepared from
these lenses as previously described [25]. Senile cataractous lenses
(classiﬁed based on pigmentation according to the Pirie classiﬁcation
[36]) were homogenized in 20 mM sodium phosphate buffer, pH 7.4
containing 200 μM EDTA (2.0 ml/lens), dialyzed against PBS, and
lyophilized. The lyophilized protein was subjected to sonication
(amplitude=30%, three 40 scycle) in 0.5 ml PBS-EDTA (200 μM).
The sonicated sample was centrifuged at 20,000 g for 30 min. Protein
concentration in the resulting supernatant was determined using the
BCA Protein Assay Kit (Thermo Scientiﬁc, Rockford, IL) and BSA as the
standard. Samples (20 μg protein) were separated by polyacryl-
amide gel electrophoresis, and Nε-acetyllysine and αB-crystallin
were detected by Western blotting using a monoclonal antibody
against Nε-acetyllysine (1:50,000 dilution, Cell Signaling Technolo-
gies, Danvers, MA) or a polyclonal antibody against αB-crystallin
(1:1000 dilution, Enzo life Sciences, Farmingdale, NY).2.2. Immunoprecipitation studies to determine acetylation and glycation
in human lens αA and αB-crystallin
Water soluble protein from three donor lenses was used. For the
detection of Nε-acetyllysine in αA- and αB-crystallin, 500 μg protein
was incubated with 5 μg of monoclonal antibody to Nε-acetyllysine.
For CML and argpyrimidine detection in αA- and αB-crystallin,
500 μg of protein was incubated with 5 μg of either mouse monoclo-
nal anti-CML (from Jes Thorn Clausen, Novo Nordisk, Germany) or
argpyrimidine antibody (from Koji Uchida, Nagoya University,
Japan) for 3 h at 37 °C followed by addition of protein A/G-Sepharose
(Santa Cruz Biotechnology, Santa Cruz, CA) and overnight incubation
at 4 °C with shaking. The sample mixture was centrifuged, and the
pellet was washed three times with PBS. The gel pellet was dissolved
in 2× SDS-PAGE sample buffer, and proteins were subjected to
electrophoresis on a 12% gel. Western blot was carried out with anti-
bodies to αA-crystallin, and αB-crystallin (Enzo life Sciences,
Farmingdale, NY).
2.3. Cloning and puriﬁcation of human αA and αB-crystallin
Cloning and puriﬁcation of αA- and αB-crystallin were done as
previously described [25].
2.4. In vitro acetylation of αA and αB-crystallin
Acetylation of αA- and αB-crystallin using lysine:Ac2O molar ra-
tios of 1:0, 1:0.05, 1:0.5, 1:1, and 1:10 was performed as previously
described [25].
2.5. Incubation of αA and αB-crystallin with MGO and ascorbate
Recombinant human αA- and αB-crystallin, either acetylated or
unacetylated (1 mg/ml) were incubated for 7 days at 37 °C in 0.1 M
sodium phosphate buffer (pH 7.4) with glycating agents: 100 μM
MGO or 10 mM ascorbate. All reaction mixtures were sterile-ﬁltered
using 0.2 μm syringe ﬁlters (Millipore Corp, MA) before incubation.
After incubation, samples were dialyzed against 2 L of PBS for 24 h,
and protein concentration was measured by the BCA method (Thermo
Scientiﬁc, Rockford, IL).
2.6. Chaperone assay with lysozyme
The chaperone assay was carried out as previously described [25]
using a ratio of αA- and αB-crystallin to lysozyme of 1:4. Brieﬂy, as-
says were carried out at 37 °C in 50 mM phosphate buffer, pH 7.4
that had 150 mM sodium chloride. The aggregation of lysozyme was
initiated by 2 mM Tris(2-carboxyethyl)phosphine (TCEP) (Thermo
scientiﬁc, Rockford, IL) and light scattering was monitored at
360 nm. Lysozyme incubated alone in the absence of α-crystallin
served as the control.
2.7. Direct ELISA for CML, HI, and argpyrimidine
Microplate wells were coated with 5 μg protein/well in 50 μl of
50 mM sodium carbonate buffer, pH 9.6, overnight at 4 °C followed by
washing three times with PBST. The wells were blocked with 5%
non-fat dry milk (NFDM) in PBST for 2 h in a humid chamber. Following
washing, mouse monoclonal antibody to CML, HI (HI monoclonal
antibody was made in mice by immunizing HI coupled to KLH)
or argpyrimidine (in PBST-NFDM) (all 1:5000 dilutions) were added
and incubated for 1 h at 37 °C. The wells were then washed three
times with PBST and incubated with goat anti-mouse antibody
(1:5000) conjugated to horseradish peroxidase (Promega, Madison,
WI). Following incubation for 1 h and washing three times with PBST,
the wells were incubated with 100 μl of 3,3′,5,5′-tetramethylbenzidine
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matic reaction was stopped at 45 min by the addition of 50 μl of 2 N
H2SO4, and the optical density of the wells was read at 450 nm in a
microplate reader.Fig. 1. Acetylation of αB-crystallin in human lens. Human lens water soluble fractions
were subjected to Western blotting with a monoclonal antibody to Nε-acetyllysine
(A). The same membrane was re-probed with a monoclonal antibody for αB-crystallin
(B). Cataractous lens proteins from grades 1 to 3 were sonicated and soluble protein frac-
tion was subjected to Western blotting with Nε-acetyllysine antibody (C).2.8. Measurement of pentosidine
Protein samples (250 μg/ml) were subjected to acid hydrolysis.
Dried samples were reconstituted in 200 μl of water and ﬁlteredFig. 2. Nε-acetylation of lysine residues and AGE formation occur in α-crystallin.
Water-soluble protein from aged donor lenses (70, 73 and 86 years old) was
immunoprecipitated (IP) with either a Nε-acetyllysine antibody (A) or a CML antibody
(B) or an argpyrimidine antibody (C) and immunoblotted (IB) with αA- and αB-crystallin
polyclonal antibodies.
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HPLC using a reversed-phase C18 column as previously described
[37]. The amino acid content of the acid hydrolysates was estimated
by the ninhydrin assay [17]. Pentosidine concentrations in the protein
samples were calculated based on standard curves generated using
synthetic compound (synthesized by the previously described proce-
dure [38]), and were expressed as pmoles/μmole of amino acid.
2.9. Measurement of apoptosis
α-Crystallin was mixed in a cationic lipid, BioPORTER, according to
the manufacturer's instructions (Gene Therapy Systems, Inc., San
Diego, CA). PBS (100 μl) containing 7.5 μg of protein was added to
each tube, thoroughly mixed by vortexing for 15 s, and then incubated
at room temperature for 5 min. Chinese hamster ovary (CHO) cells
were cultured in Ham's F12media supplemented with 10% fetal bovine
serum. When cells were 80% conﬂuent, adherent cells were treated
with BioPORTER alone or BioPORTER containing proteins in serum
free media. Cells were incubated for 4 h at 37 °C in a humidiﬁed 5%
CO2 atmosphere, and then washed with PBS. The cells were incubated
at 43 °C for 1 h, followed by incubation at 37 °C for 24 h. The percent-
age of apoptotic cells was determined by staining the cells with
Hoechst 33342.
2.10. Measurement of caspase-3 activity
Protein lysates (100 μg) were incubated with 0.2 mM Ac-DEVD-AFC
(acetyl-DEVD-7-amino-4-triﬂuoromethylcoumarin) at 37 °C for 60 min
in HEPES-buffer [20 mM HEPES, pH 7.5, 10% glycerol, and 2 mM DTT
(dithiothreitol)] after thermal stress (43 °C for 60 min). AFC (7-amino-Fig. 3. Nε-acetylation of lysine residues decreases AGE-mediated crosslinking in α-crys
molar excesses (relative to lysine) of Ac2O. Unacetylated and acetylated αA andαB-cryst
A,αA-crystallin glycated with MGO; B,αA-crystallin glycated with ascorbate; C,αB-crys
1 = unacetylated protein, lane 2 = glycated protein, lanes 3 to 6 are glycated and acety
weight markers. Arrow indicates αA or αB-crystallin in samples.4-triﬂuoromethylcoumarin) released from the substrates was measured
using a microtiter plate reader with an excitation wavelength of 400 nm
and an emission wavelength of 505 nm.
2.11. Statistics
Results are given as the mean±SD. Statistical signiﬁcance was de-
termined by two-tailed t test. Values of pb0.05 were considered to be
signiﬁcant.
3. Results
3.1. Acetylation of αB-crystallin in human lens
The effect of age and cataract on lysine acetylation in human lens
αB-crystallin was investigated. Normal lenses of varying age along
with cataractous lenses were analyzed. Immunoblotting with an anti-
body to Nε-acetyllysine showed considerable heterogeneity in the re-
action with the antibody, revealing multiple immunoreactive protein
bands with strong reactions in the 20–25 and the 40–45 kDa regions
in all normal lenses (Fig. 1A). In aged lenses (>60 years) high molec-
ular weight proteins (>50 kDa) also reacted with the antibody. The
immunoblotted membrane was stripped and probed again with an
antibody to αB-crystallin. The results showed immunoreactivity for
Nε-acetyllysine coinciding with that of αB-crystallin, suggesting that
αB-crystallin is acetylated in human lens proteins (Fig. 1B). We
then investigated the effect of cataract on Nε-acetylation of
α-crystallin. Western blot analysis showed immunoreactivity in pro-
teins of molecular weight ~20 kDa along with high molecular weight
aggregates (Fig. 1C).tallin. Human αA- and αB-crystallin were acetylated with 0.05, 0.5, 1, and 10 fold
allin were then glycated with MGO or ascorbate and subjected to SDS-PAGE analysis.
tallin glycated with MGO; D, αB-crystallin glycated with ascorbate. In all panels, lane
lated, respectively, with 0.05, 0.5, 1, and 10 fold molar excess Ac2O. M = molecular
Fig. 4. Effect of Nε-acetylation and glycation on the chaperone function of α-crystallin.
The chaperone function of unacetylated and acetylated αA-crystallin (A) and
αB-crystallin (B) after glycation with either 100 μM MGO or 10 mM ascorbate (ASC)
for one week was assessed using lysozyme as the client protein. Acetylation was carried
out with 10 molar excess of Ac2O in relation to lysine content in α-crystallin. MGO =
methylglyoxal, ASC = ascorbate. Each bar represents the mean±SD of three experi-
ments. *pb0.05, **pb0.005 and ***pb0.0005 compared to unmodiﬁed α-crystallin.
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To determine if both Nε-acetylation of lysine and AGEs occur in
αA- and αB-crystallin, water-soluble protein from three aged donor
lenses (70, 73 and 86 years old) were immunoprecipitated with ei-
ther Nε-acetyllysine or CML or argpyrimidine monoclonal antibody
andWestern blotted with anti αA- or an anti αB-crystallin polyclonal
antibody. The results conﬁrmed that Nε-acetylation of lysine residues
occurs in both αA- and αB-crystallin (Fig. 2A). We then investigated
the co-existence of AGEs and acetylated lysine in α-crystallin by
Western blotting. Water-soluble protein was immunoprecipitated
using CML antibody and probed with either αA- or αB-crystallin an-
tibody. CML was identiﬁed in both αA- and αB-crystallin (Fig. 2B).
Similarly, argpyrimidine was preseent in both αA- and αB-crystallin
(Fig. 2C). Immunoreactions with higher molecular proteins could be
due to the presence of AGEs and acetylated α-crystallin in crosslinked
proteins. Together, these results suggest that AGE formation and
Nε-acetylation of lysine residues concurrently occur in α-crystallin,
but whether they occur in the same molecule of α-crystallin needs
to be veriﬁed.
3.3. Nε-acetylation of lysine residues decreases AGE-mediated crosslinking
in αA- and αB-crystallin
To determine the effect of prior acetylation on glycation, chaper-
one, and anti-apoptotic function of α-crystallins, recombinant αA-
and αB-crystallin were acetylated using Ac2O. We used a 0.05, 0.5,
1, and 10 fold molar excess of Ac2O relative to the lysine content
(considering 7 lysine residues per molecule of αA-crystallin and 10
lysine residues in αB-crystallin) for the acetylation studies. To con-
ﬁrm acetylation in α-crystallin, Western blotting was carried out
with the Nε-acetyllysine antibody. Results showed strong reaction
with αA- and αB-crystallin, and the intensity of the reaction in-
creased with increasing concentrations of Ac2O (Fig. S1B and D).
The acetylated and unacetylated proteins were glycated with MGO
or ascorbate. In the case of αA-crystallin, glycation by MGO resulted
in high molecular weight crosslinked proteins at the top of the run-
ning gel, which poorly penetrated the gel (Fig. 3A, lane 2). Extensive
crosslinking was also observed in proteins glycated with ascorbate,
but the crosslinked proteins were resolved in the running gel
(Fig. 3B, lane 2). With αB-crystallin, glycation by MGO resulted in
less severe crosslinking (compared to αA-crystallin) (Fig. 3C, lane
2). Similarly, glycation by ascorbate resulted in extensive crosslinking
of αB-crystallin (Fig. 3D, lane 2). Prior Nε-acetylation of lysine resi-
dues before glycation with either MGO or ascorbate inhibited protein
crosslinking in both proteins in a manner dependent on the degree of
acetylation (Fig. 3A and B); the greatest inhibition was seen in pro-
teins acetylated with a 10 fold molar excess of Ac2O (lanes 6 in each
panel).
3.4. Effect of lysine acetylation and glycation on the chaperone function
of α-crystallin
We investigated the effect of prior lysine acetylation on
glycation-induced changes in the chaperone function of αA- and
αB-crystallin in the thermal aggregation assay of lysozyme. In these
experiments we used proteins that were acetylated with 10 fold
molar excess of Ac2O. Glycation with ascorbate resulted in decreased
chaperone function in both αA- and αB-crystallin compared to the
unmodiﬁed protein (Fig. 4A and B). Glycation of αA-crystallin with
MGO increased the chaperone function of αA-crystallin by ~40%
(Fig. 4A), as previously reported [39], but did not affect the chaperone
function of αB-crystallin (Fig. 4B). Prior acetylation further improved
the chaperone function of MGO-modiﬁed αA-crystallin by ~20% and
partially prevented the loss of chaperone function in αA-crystallin
glycated with ascorbate. The chaperone function of αB-crystallinincreased by ~25% after acetylation similar to αA-crystallin, and
remained unchanged by MGO modiﬁcation. Ascorbate-mediated
loss in chaperone function (~40%) was partially corrected by prior
acetylation (Fig. 4B). Taken together, these results suggest that lysine
acetylation improves the chaperone function in both proteins, and
MGO-glycation further improves the chaperone function of αA-
crystallin, and prior lysine acetylation inhibits the loss of chaperone
function by ascorbate-glycation in both αA- and αB-crystallin.3.5. Effect of lysine acetylation on AGE formation in α-crystallin
To test the effect of lysine acetylation on AGE formation, we mea-
sured CML, argpyrimidine, HI, and pentosidine in acetylated+glycated
protein preparations. CML, HI, and argpyrimidine were measured by
direct ELISA. While HI is speciﬁc for MGO, CML and argpyrimidine are
formed from both MGO and ascorbate. In αA-crystallin, lysine acetyla-
tion decreased CML formation from ascorbate in a progressive manner;
with a 10 fold molar excess of Ac2O there was a ~40% decrease
(Fig. 5A). However, in αB-crystallin there was a signiﬁcant (~80%) de-
crease with mildly acetylated protein (0.05 molar excess Ac2O)
(Fig. 5B), which slightly further decreased (~85%) with 10 fold molar
excess Ac2O acetylated protein.
HI levels were high in both αA- and αB-crystallin glycated with
MGO, and HI levels progressively decreased with increasing acetylation
in both proteins (Fig. 5C and D). The effect on argpyrimidine formation
was similar to that of HI (Fig. 5E and F); the degree of inhibition was
directly proportional to the degree of lysine acetylation. Glycation
Fig. 5. Nε-acetylation inhibits AGE formation in α-crystallin. AGE synthesis of unacetylated and acetylated αA- and αB-crystallins after glycation with either MGO or ascorbate was
determined by direct ELISAs. The effect on the CML formation in αA and αB-crystallin is shown in A and B. The effect on HI formation in αA- and αB-crystallin is shown in C and D.
The effect on argpyrimidine formation in αA- and αB-crystallin is shown in E and F. In each panel 1 = unacetylated protein and 2 to 5 = protein acetylated with 0.05, 0.5, 1.0, and
10 fold molar excess Ac2O. Each bar represents the mean±SD of three experiments. ***pb0.0005 (compared to lane 1 in each case).
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αA-crystallin, and produced none in αB-crystallin.
The effect of acetylation on pentosidine synthesis was then inves-
tigated. While pentosidine readily formed from ascorbate in both αA-
and αB-crystallin (Fig. 6), it was not formed with MGO. Pentosidine
synthesis from ascorbate was higher in αB-crystallin (Fig. 6B)
compared to αA-crystallin (Fig. 6A). Lysine acetylation reduced
pentosidine synthesis from ascorbate mostly in αB-crystallin. With
highest acetylation, the inhibition was ~8% and ~50% in αA- and
αB-crystallin, respectively. Together, these data suggest that prior
acetylation of lysine residues inhibits AGE formation in α-crystallin.
The previous observations that aspirin inhibits sugar-mediated
crosslinking of lens proteins [40,41] could be due to inhibition of
crosslinking AGEs.
3.6. Effect on the anti-apoptotic function of αA and αB-crystallin
Next, we investigated the effects of acetylation and glycation on the
anti-apoptotic function of αA and αB-crystallin in CHO cells upon
heat stress. Native, acetylated, and acetylated+glycated αA- andαB-crystallin were transferred to CHO cells using a cationic lipid
BioPORTER. Cells were stressed at 43°C for 1 h to induce apoptosis. Ther-
mal stress induced apoptosis in nearly 30% of cells (Fig. 7). Introduction
of αA-crystallin reduced this apoptosis to ~10%. αA- and αB-crystallin
acetylated at 10 fold molar excess Ac2O signiﬁcantly inhibited apoptosis
compared to the unmodiﬁed protein. The anti-apoptotic function of
unacetylated and acetylated αA-crystallin was enhanced by glycation
with MGO. The apoptotic cell number dropped to ~7% and ~3%, respec-
tively, after glycation of unacetylated and acetylated αA-crystallin with
MGO. The function of acetylated+MGO-glycated protein was slightly
weaker than the MGO glycated protein (Fig. 7A), with the exception of
protein acetylated with a 10 fold molar excess Ac2O. Glycation with
ascorbate surprisingly improved the anti-apoptotic function of αA-
crystallin, although at high levels of acetylation (10 fold molar excess
Ac2O) there was a decrease in the anti-apoptotic function (12% when
compared to 3% with ascorbate glycated protein).
αB-Crystallin was as effective as αA-crystallin in inhibiting ther-
mally induced apoptosis in CHO cells; the fraction of apoptotic cells
decreased from ~30% to ~10% (Fig. 7B). Lysine acetylation enhanced
this anti-apoptotic function; the percent of apoptotic cells dropped
Fig. 6. Nε-acetylation inhibits pentosidine formation from ascorbate in α-crystallin.
Unacetylated and acetylated αA-crystallin (A) and αB-crystallin (B) was incubated
with ascorbate for one week. Pentosidine was measured by ﬂuorescence HPLC.
Fig. 7. Effect of Nε-acetylation and glycation on the anti-apoptotic function of αA- and
αB-crystallin. α-Crystallin (unmodiﬁed, acetylated, and acetylated+glycated) (7.5 μg
of protein) was treated with BioPORTER and added to the media of CHO cells when
they reached 80% conﬂuence. Cells were incubated at either 37 °C or 43 °C for 1 h,
followed by incubation at 37 °C for 24 h. The percentage of apoptotic cells was deter-
mined by staining cells with Hoechst 3334. Panel A = αA-crystallin and panel B =
αB-crystallin. In each panel, 1 = unmodiﬁed protein and 2 to 5 = protein acetylated
with 0.05, 0.5, 1.0, and 10 fold molar excess Ac2O or acetylated and glycated. Each
bar represents the mean±SD of three experiments. *pb0.05, **pb0.005 (compared
to lane 1 in each case) and ***pb0.0005 (comparing cells at 43 °C to cells at 37 °C).
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of Ac2O. Glycation by MGO further increased the anti-apoptotic func-
tion of unacetylated protein (percent apoptotic cells=2%), but did
not signiﬁcantly alter the anti-apoptotic function of acetylated
αB-crystallin. However, protein acetylated with 10 fold molar excess
Ac2O and glycated with MGO was less efﬁcient than acetylated but
not glycated protein. Glycation by ascorbate signiﬁcantly reduced
the anti-apoptotic function of αB-crystallin. However, prior lysine
acetylation before glycation limited this loss in anti-apoptotic func-
tion. Together, these data suggest that glycation by MGO and lysine
acetylation make both αA- and αB-crystallin better anti-apoptotic
proteins, while glycation by ascorbate reduced the anti-apoptotic
function of αB-crystallin without a signiﬁcant affect on αA-crystallin.
To determine if apoptosis occurred as a result of caspase-3 activa-
tion in the above experiment, we measured enzyme activity using
DEVD as substrate. Caspase-3 activity increased by ~50% in thermally
stressed CHO cells (Fig. 8), which was inhibited by ~5% and ~55%,
respectively, by αA- and αB-crystallin. Lysine acetylation of both αA-
and αB-crystallin provided better protection against caspase-3 activity,
although the effect was more pronounced with αB-crystallin. Transfer
of MGO-glycated protein further reduced caspase-3 activity by ~60%
and ~65% in αA- and αB-crystallin. Light acetylation together with
MGO glycation slightly lowered the ability of both αA- and αB-
crystallin to inhibit caspase-3 activity. On the other hand, acetylation
and ascorbate glycation increased the ability of αA-crystallin to inhibit
caspase-3 activity compared to unacetylated αA-crystallin. A similar,
but less apparent, increase was observed with αB-crystallin. These re-
sults imply that αB-crystallin and, to a somewhat lesser extent,
αA-crystallin can block caspase-3 activity in thermally stressed CHO
cells, and this function was retained in acetylated and acetylated+
glycated proteins.4. Discussion
The purpose of our study was to determine the combined effect of
acetylation and AGE formation on two important functions of
α-crystallin, viz., chaperone and anti-apoptosis. Previously, we had
shown that acetylation occurs in human lens αA- and αB-crystallin,
and enhances the chaperone function of αA-crystallin [25]. In this
study we found that such acetylation also enhances the chaperone
function of αB-crystallin. We analyzed acetylation status of αB-
crystallin in lens water-soluble proteins from donors of age between
15 and 86 and found that acetylation of αB-crystallin occurs very
early in age and remains throughout life. Previously we had shown
that αA-crystallin is also acetylated at an early age in human lenses
[25]. Together, these observations suggest that acetylation could be
necessary for maintaining chaperone function of α-crystallin. With
regard to lysine acetylation, it is not clear whether it is mediated
by lysine acetyl transferase, or if it is formed from other post-
translational modiﬁcation, such as glycation as reported recently [42].
Glycation occurs in lens proteins throughout life, but is minimal in
young lenses. Relatively high levels are found usually in aged and
cataractous lenses [35]. This suggests that AGE formation is promoted
by conditions in aged and cataractous lenses. One mechanism could
be through oxidation of ascorbate due to oxidative stress or loss of
GSH in aged lenses, which could lead to production of highly reactive
sugars that can form AGEs [43–46]. The loss of GSH might also reduce
the activity of GSH-dependent glyoxalase leading to decreased me-
tabolism of MGO, and consequently, to formation of MGO-mediated
Fig. 8. Effect of Nε-acetylation and glycation of α-crystallin on caspase-3 activity in CHO
cells. Conditions were the same as in Fig. 7. Caspase-3 activity was measured using
Ac-DEVD-AFC substrate. In each panel 1 = unacetylated and 2 to 5 = acetylated with
0.05, 0.5, 1.0, and 10 fold molar excess Ac2O. Panel A = αA-crystallin and panel B =
αB-crystallin. Each bar represents the mean±SD of three experiments. *pb0.05 (com-
pared to lane 1 in each case) and ***pb0.0005 (comparing cells at 43 °C to cells at 37 °C).
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curs early in life, and remains throughout life, lysine acetylation
might be an inhibitory mechanism against AGE formation, as lysine
is a major site for AGE formation. This may be particularly important
for ascorbate-mediated glycation, as lysine residues are primary
targets in those reactions, unlike MGO-mediated glycation, in which
arginine residues are the primary targets.
Our immunoprecipitation studies revealed that AGEs and acetylat-
ed lysine residues are together present in αA- and αB-crystallin mod-
iﬁcations. This implies that these two types of modiﬁcations can occur
concurrently in α-crystallin, and can change its function in aged and
cataractous lenses. This observation led us to acetylate lysine residues
followed by glycation with MGO or ascorbate, and to then determine
the effects on two major functions of α-crystallin, chaperoning of
destabilized proteins and inhibition of apoptosis.
We tested the effect of acetylation on glycation by two methods. In
the ﬁrst, we analyzed acetylated and glycated proteins by SDS-PAGE for
protein crosslinking, as many AGEs are formed as crosslinking adducts
in proteins [35]. Prior lysine acetylation decreased protein crosslinking
by glycation by bothMGO and ascorbate, suggesting broad inhibition in
AGE synthesis. If this phenomenon were occurring in the lens, lysine
acetylation at a young age could help lens proteins remain soluble by
limiting AGE-mediated protein crosslinking. In the second method,
speciﬁc AGEs were measured. We measured HI and argpyrimidine,
which are arginine modiﬁcations, CML, which is a lysine modiﬁcation,
and pentosidine, which is a lysine-arginine crosslinking modiﬁcation.
Prior acetylation largely inhibited formation of these AGEs. The inhibi-
tion of AGE formation by lysine acetylation thus controls AGE accumu-
lation in lens proteins during aging. These observations lead to an
important question—how does acetylation of lysine residues inhibitHI and argpyrimidine formation in α-crystallin? In our previous
study, we showed that acetylation leads to structural perturbations in
α-crystallin [25]. It is possible that such structural changes could lead
to masking of arginine residues, which otherwise would be available
for HI and argpyrimidine modiﬁcations.
As we reported previously [25,48–49], both MGO-glycation and
acetylation improved the chaperone function of αA-crystallin. The ob-
servation in this study that prior acetylation further improves MGO-
mediated effects on the chaperone function of αA-crystallin points to
an additive effect of these twomodiﬁcations. Further, lysine acetylation
partially prevented the loss of chaperone function by ascorbate-
glycation in both αA- and αB-crystallin. This is not surprising because
ascorbate glycation mainly occurs on lysine residues, and therefore,
prior lysine acetylation could have prevented glycation by ascorbate,
and hence, the loss of chaperone function. In agreement with our pre-
vious observation [50], MGO-glycation did not improve the chaperone
function of αB-crystallin. Why the MGO-mediated improvement in
chaperone function is speciﬁc to αA-crystallin is not known and
needs further investigation.
We also investigated the effect of acetylation and glycation on the
other important function of α-crystallin, its ability to prevent apoptosis
in cells experiencing external stresses. In this study we used thermal
stress in CHO cells to interrogate the effects. CHO cells provided a
clean background for the study as they lack α-crystallin. Previous stud-
ies, including our own, have shown that α-crystallin inhibits apoptosis
by binding to procaspase-3 and Bax, inhibiting cytochrome-c release,
activating PI3 kinase, activating PDK-1 and AKT, and inhibiting PTEN
[9–12]. The transfer of both αA- and αB-crystallin resulted in a signif-
icant inhibition of apoptosis. This appears to be due to inhibition of
caspase-3 activity. The increase in anti-apoptotic property by acetyla-
tion in both proteins suggests that acetylation of α-crystallin within
lens epithelial cells would enhance protection offered by α-crystallin
against metabolic and environmental stresses. The fact that glycation
by either MGO or ascorbate did not drastically change this property
indicates that the anti-apoptotic property is resistant to these post-
translational modiﬁcations. An interesting observation is that, while
the chaperone function of αB-crystallin was not improved by MGO-
glycation, its anti-apoptotic property was signiﬁcantly improved. This
suggests that there is disconnect between the chaperone and
anti-apoptotic functions in αB-crystallin, unlike in αA-crystallin [9].
In summary, the ﬁndings in this study suggest that the lysine acet-
ylation that occurs early in life in α-crystallin helps the protein retain
its function in thwarting ill effects from ascorbate-glycation during
aging.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbadis.2012.08.015.
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